The Journal of Immunology, Vol 154, Issue 11 5736-5745, Copyright © 1995 by American Association of Immunologists

ARTICLES

T cell development in insulin-like growth factor-II transgenic mice

R Kooijman, SC van Buul-Offers, LE Scholtens, HJ Schuurman, LJ Van den Brande and BJ Zegers
Department of Immunology, University Hospital for Children and Youths, Utrecht, The Netherlands.

Growth hormone and insulin-like growth factor-I (IGF-I) have been demonstrated to play a role in T and B cell development. We studied the effects of IGF-II on T cell development in two transgenic mouse lines that overexpress human IGF-II under the control of the H2Kb promoter. The thymuses of 1-wk-old mice of two transgenic lines (5'-35 and 5'-74) contained 36 and 68%, respectively, more thymocytes than controls. Between 1 and 4 wk of age, the overexpression of IGF-II also resulted in a 2 to 2.5 times stronger increase in thymic cellularity. As in control mice, the number of thymocytes declined after 4 wk of age, and at 15 wk it was no longer significantly different from controls. Flowcytometric analysis indicated that at 2 and 4 wk of age, the increased thymic cellularity was associated with an increased number of early (CD4- CD8- or CD4- CD8dim), intermediate (CD4+CD8+), and mature thymocytes (CD3++CD4+CD8- or CD3++CD4-CD8+). However, the increase in the number of CD4+CD8- thymocytes was larger than the increase in the number of CD4-CD8+ thymocytes. As a consequence, CD4+ T cells mainly contributed to the increase in the number of T cells in spleen. These T cells showed a mature phenotype since they expressed CD3 and were negative for heat-stable antigen, a marker for immature T cells. These data indicate that overexpression of IGF-II increases thymic cellularity and stimulates the generation of phenotypically normal T cells with a preference to CD4+ cells.

This article has been cited by other articles:

				I. Hansenne, C. Renard-Charlet, R. Greimers, and V. Geenen Dendritic cell differentiation and immune tolerance to insulin-related peptides in igf2-deficient mice. J. Immunol., April 15, 2006; 176(8): 4651 - 4657. [Abstract] [Full Text] [PDF]

				A. Baez-Saldana and E. Ortega Biotin Deficiency Blocks Thymocyte Maturation, Accelerates Thymus Involution, and Decreases Nose-Rump Length in Mice J. Nutr., August 1, 2004; 134(8): 1970 - 1977. [Abstract] [Full Text] [PDF]

				C. C. Zhang and H. F. Lodish Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells Blood, April 1, 2004; 103(7): 2513 - 2521. [Abstract] [Full Text] [PDF]

				L. Rodriguez-Borlado, D. F. Barber, C. Hernandez, M. A. Rodriguez-Marcos, A. Sanchez, E. Hirsch, M. Wymann, C. Martinez-A., and A. C. Carrera Phosphatidylinositol 3-Kinase Regulates the CD4/CD8 T Cell Differentiation Ratio J. Immunol., May 1, 2003; 170(9): 4475 - 4482. [Abstract] [Full Text] [PDF]

				W. Savino and M. Dardenne Neuroendocrine Control of Thymus Physiology Endocr. Rev., August 1, 2000; 21(4): 412 - 443. [Abstract] [Full Text] [PDF]

				O. Kecha, F. Brilot, H. Martens, N. Franchimont, C. Renard, R. Greimers, M.-P. Defresne, R. Winkler, and V. Geenen Involvement of Insulin-Like Growth Factors in Early T Cell Development: A Study Using Fetal Thymic Organ Cultures Endocrinology, March 1, 2000; 141(3): 1209 - 1217. [Abstract] [Full Text] [PDF]

				C. S. Freitas, S. R. Dalmau, and W. Savino Epidermal Growth Factor (EGF) Modulates Fetal Thymocyte Growth and Differentiation: Partial Reversal by Insulin, Mimicking by Specific Inhibitors of EGF Receptor Tyrosine Kinase Activity, and Differential Expression of CD45 Phosphatase Isotypes J. Immunol., October 1, 1998; 161(7): 3384 - 3392. [Abstract] [Full Text] [PDF]

				P. Vafiadis, S. T. Bennett, J. A. Todd, R. Grabs, and C. Polychronakos Divergence between Genetic Determinants of IGF2 Transcription Levels in Leukocytes and of IDDM2-Encoded Susceptibility to Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2933 - 2939. [Abstract] [Full Text]

				R. Clark The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function Endocr. Rev., April 1, 1997; 18(2): 157 - 179. [Abstract] [Full Text]